ArticleCancer research and treatment2024

Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non-Small Cell Lung Cancer.

Beung-Chul Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.